2024-04-17 11:27:00 ET
Summary
- Eli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea.
- Abbott posts Q1 results beat, Travelers earnings hurt by elevated catastrophe losses.
- Mortgage servicing within housing-finance will benefit from a higher-for-longer rate environment - Wedbush.
Listen below or on the go on Apple Podcasts and Spotify
Zepbound sees positive outcomes in Phase 3 clinical trials for sleep disorder. (0:16) Walmart teams up with Jessica Simpson. (3:25) Cathie Wood's flagship ARRK ETF f alls below key technical level. (3:42)...
Read the full article on Seeking Alpha
For further details see:
Wall Street Lunch: Lilly In Limelight